CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 200 filers reported holding CHEMOCENTRYX INC in Q4 2020. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $63,000 | -84.5% | 1,212 | -92.6% | 0.00% | -85.7% |
| Q2 2022 | $406,000 | +21.6% | 16,384 | +22.9% | 0.01% | +40.0% |
| Q1 2022 | $334,000 | -21.2% | 13,332 | +14.6% | 0.01% | -16.7% |
| Q4 2021 | $424,000 | +6.3% | 11,633 | -50.2% | 0.01% | -14.3% |
| Q3 2021 | $399,000 | +191.2% | 23,340 | +128.2% | 0.01% | +250.0% |
| Q2 2021 | $137,000 | -100.0% | 10,226 | -55.7% | 0.00% | -80.0% |
| Q1 2021 | $1,181,594,000 | +457882.2% | 23,060 | +453.4% | 0.01% | +66.7% |
| Q4 2020 | $258,000 | +85.6% | 4,167 | +64.6% | 0.01% | +50.0% |
| Q3 2020 | $139,000 | +167.3% | 2,531 | +180.3% | 0.00% | +300.0% |
| Q2 2020 | $52,000 | +420.0% | 903 | +252.7% | 0.00% | – |
| Q1 2020 | $10,000 | – | 256 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 545,532 | $13,518,000 | 5.54% |
| Integral Health Asset Management, LLC | 574,029 | $14,224,000 | 2.93% |
| HealthCor Management, L.P. | 1,097,370 | $27,193,000 | 2.73% |
| Logos Global Management LP | 600,000 | $14,868,000 | 2.73% |
| Cormorant Asset Management, LP | 1,425,000 | $35,312,000 | 2.67% |
| Altium Capital Management LP | 160,000 | $3,965,000 | 1.59% |
| Cahill Wealth Management, LLC | 68,358 | $1,693,000 | 1.43% |
| Hood River Capital Management LLC | 1,336,776 | $33,125,000 | 1.32% |
| Sofinnova Investments, Inc. | 636,659 | $15,776,000 | 1.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,000 | $121,100,000 | 1.26% |